Colorectal Adenocarcinoma — Trials

Colorectal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

367 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 114
Recruiting: 64
Ph III recruiting: 4
Growth YoY: −9.7%
Industry share: 15%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 38.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (54)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04111172	A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma	suspended	Phase 2	48	Thomas Jefferson UniversityOTHER	1	Sep 14, 2026	clinicaltrials
NCT05200442	A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer	suspended	Phase 1 / Phase 2	53	University of ChicagoOTHER	1	May 8, 2026	clinicaltrials